Correlation of bone metabolism serum markers with clinical parameters of the disease progression during 2-year follow-up in patients with chronic obstructive pulmonary disease.

Tanya Tacheva, Dimo Dimov, Yanitsa Zhelyazkova, Elina Aleksandrova, Petya Stamenova, Tatyana Vlaykova

Abstract read

In one paragraph

Article in Tzu chi medical journal. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tanya TachevaDepartment of Medical Chemistry and Biochemistry, Medical Faculty, Trakia University, Stara Zagora, Bulgaria.

Dimo DimovDepartment of Medical Chemistry and Biochemistry, Medical Faculty, Trakia University, Stara Zagora, Bulgaria.

Yanitsa ZhelyazkovaDepartment of Medical Chemistry and Biochemistry, Medical Faculty, Trakia University, Stara Zagora, Bulgaria.

Elina AleksandrovaDepartment of Medical Chemistry and Biochemistry, Medical Faculty, Trakia University, Stara Zagora, Bulgaria.

Petya StamenovaMedical Faculty, Trakia University, Stara Zagora, Bulgaria.

Tatyana VlaykovaDepartment of Medical Chemistry and Biochemistry, Medical Faculty, Trakia University, Stara Zagora, Bulgaria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Although chronic obstructive pulmonary disease (COPD) primarily affects the lungs, it is accepted that COPD is a complex multicomponent disease characterized by chronic systemic inflammation, often with other comorbidities, which are important determinants associated with increased risk of health deterioration, hospitalization, and mortality. One of the most common comorbidities in COPD is osteoporosis. The aim of the study was to explore the possible role of three serum markers of bone metabolism, 25-hydroxyvitamin D Materials and Methods: We assessed the serum levels of these markers in 23 control individuals and in 58 patients with COPD, followed for 2 years after recruitment in the current study. Results: All examined serum markers were significantly lower in COPD patients in comparison to controls ( Conclusion: The results suggest that the higher serum OPG and Vitamin D

Indexed as

Bone metabolismChronic obstructive pulmonary diseaseOsteoporosisVitamin D3

Identifiers

PMID42131410

DOI10.4103/tcmj.tcmj_175_25

PMCPMC13167094

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC-SA

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.